|

Mg OSTEOCRETE Post-Treatment Outcomes

RECRUITINGSponsored by Santiago Lozano-Calderon
Actively Recruiting
SponsorSantiago Lozano-Calderon
Started2025-03-17
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* 18 years of age and older on the day of surgery
* has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product
* Mg OSTEOCRETE is indicated for one of the following reasons:

  1. as a bone void filler following bone tumor resection, or;
  2. as an augment for defects causing aseptic loosening of orthopaedic implants, or;
  3. to help substitute bone for trauma-related conditions

Exclusion Criteria:

* any contraindication as per Instructions for Use for Mg OSTEOCRETE

Conditions4

Aseptic Loosening of Orthopaedic HardwareCancerCancer of BoneTrauma

Locations1 site

Massachusetts General Hospital
Boston, Massachusetts, 02114
Shreya Halur, BS617-726-4932shalur@mgh.harvard.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.